Ketahui lebih banyak tentang penyebab dan cara mengatasi bayi alergi telur. Berikut adalah hal-hal yang perlu Anda ketahui ...

Doctors report a steady increase in eczema cases among infants across Indian cities. Experts warn that genetics and environmental factors are key drivers behind this troubling trend.

Atopic dermatitis or eczema can impact patients of all skin types and all backgrounds, but those are some of the variables that contribute.

In this video, Robert J. Smith, MD, discusses ways to approach hard-to-treat atopic dermatitis.

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

The Phase 1b trial is designed to evaluate the safety, tolerability, pharmacokinetics, target engagement, and early signs of efficacy of ENV-294 in patients with moderate to severe atopic dermatitis.

Nektar Therapeutics’ biologic drug rezpegaldesleukin takes a new approach to atopic dermatitis, or eczema, stimulating proliferation of immune cells that tamp down excessive immune responses ...

Nektar Therapeutics said a study of rezpegaldesleukin showed that the atopic dermatitis treatment met key endpoints. The clinical-stage biotechnology company said data from the 16-week induction ...

to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical ...

How do dermatologists diagnose atopic dermatitis? To diagnose atopic dermatitis, also called eczema, a board-certified dermatologist carefully examines your (or your child's) skin and asks ...

New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or ...